Associated Papers
Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's disease.
Tsaka G et al.
The Journal of Biological Chemistry, 2026
Seeding Alzheimer's disease-associated tau pathology in MAPT knock-in primary neurons causes early axonopathy and synaptic dysfunction.
Mueller RL et al.
Scientific Reports, 2025
Distinct regulation of Tau Monomer and aggregate uptake and intracellular accumulation in human neurons.
Marvian AT et al.
Molecular Neurodegeneration, 2024
DNAJB8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity.
Ryder BD et al.
Structure (london, England : 1993), 2024
Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects.
Lathuilière A et al.
Scientific Reports, 2017
Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo.
Yanamandra K et al.
Neuron, 2013
Select a paper to view details